Innovative Frontiers: AI-Driven Approaches to Microbiological Analysis

An open discussion about the future of microbiological analysis through AI integration with Franco Pirovano (Micro srl) and Federico Pirovano (Dynius).

Engineering Live biotherapeutics to treat complex respiratory diseases

Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…

Innovative clinical trial targets Parkinson’s disease through intestinal microbiome study

The study seeks to identify specific microbial and metabolic markers in the small intestinal fluid and blood of PD patients, offering new avenues for therapeutic intervention.

Study reveals the trajectory of phages in the infant gut ecosystem

The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.

Gut microbes influence cognitive performance in baby mice

The findings of a recent study show that specific gut microbes and their metabolites affect cognition and memory when transplanted into germ-free mice.

The role of gut microbiota and mycobiota in pre-eclampsia

Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.

The cloudy link between gut microbes and obesity

Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.

Study characterizes the microbiota of milk from mothers with preterm infants

The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…

IBS DAYS 2024 in Bologna with experts from all over the world 

Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.

AI and the Microbiome: Crafting the Future of Health with Evogene and Verb Biotics

Two pioneering companies are poised to explore the genetic frontiers of probiotic bacteria, seeking out strains that can produce sustainable quantities of life-enhancing microbial metabolites.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.